Evidence map›Paper›PMID 38702942›Full record

ArticlePhotochemistry and photobiology

Film dosimetry for occupant exposure monitoring within Far-UVC installations.

David Welch, Raabia Hashmi, Camryn Petersen, Steven Erde, David J Brenner, Edward Nardell

Abstract read
In one paragraph

Article in Photochemistry and photobiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

David WelchCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York, USA.
Raabia HashmiCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York, USA.
Camryn PetersenCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York, USA.
Steven ErdeCollege of Dental Medicine, Columbia University Irving Medical Center, New York, New York, USA.
David J BrennerCenter for Radiological Research, Columbia University Irving Medical Center, New York, New York, USA.
Edward NardellDivision of Global Health Equity, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-5323-3196

Funding

Testing health hazards from implementation of far-UVC irradiation as an intervention technology to reduce airborne disease transmissionR01OH012312 · OH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WELCH, DAVID · 2022 to 2025
$2.6M
Columbia University Urban Tech AwardEmpire State Biodefense Commercialization FundNIOSH CDC HHS R01 OH012312NIOSH CDC HHS R01OH012312Open Philanthropy Foundation
6 · The paper itself

Abstract

Far-UVC radiation between 200 and 230 nm is a promising technology for reducing airborne disease transmission. Previous work with far-UVC lamps has demonstrated the efficacy of far-UVC radiation to inactivate bacteria and viruses while presenting minimal human health hazards. While far-UVC intentionally exposes the occupied space, effectively disinfecting air between occupants, installations must still ensure that occupant eye and skin exposure is within the recommended daily limits. This study examines far-UVC-sensitive films for measuring the dose received by occupants within two real-world far-UVC installations. The film is characterized for accuracy, angular response, wavelength response, and sources of uncertainty in film response, and used to obtain individual exposure doses that account for both the non-uniform irradiance and the unique motion of individuals within the space. Dosimetry results using the films, which account for the time-weighted average exposure of an occupant, ranged from 10% to 49% of the maximum calculated stationary dose based on peak irradiance measurements. Results from this study spotlight the need to incorporate time-weighted average considerations into the design and safety assessment of far-UVC installations to ultimately operate far-UVC technology with its full potential to prevent the spread of potentially fatal infectious diseases.

Indexed as

Film DosimetryUltraviolet RaysHumansexposure monitoringfar‐UVCfilm dosimetry

Identifiers

PMID38702942
PMCPMC11737010

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.